BlackRock Defensive Advantage Emerging Markets Fund SAU:4164 Holdings History
BlackRock Defensive Advantage Emerging Markets Fund's Nahdi Medical Co Holding Summary
As of 2025-04-30, BLACKROCK FUNDS held 5,298.00 shares of Nahdi Medical Co(SAU:4164), totaling ï·¼160,450.00. This investment constitutes 1.46% of their stock portfolio, and BLACKROCK FUNDS now holds 0% of the outstanding Nahdi Medical Co(SAU:4164) stock.
The initial trade took place in 2023Q2. And since then BlackRock Defensive Advantage Emerging Markets Fund has made 6 purchases of SAU:4164, at an average price of ï·¼138.92, for a total of 9,411.00 shares. In addition, there have been 1 sales at an average price of ï·¼133.25 for 4,113.00 shares. Based on historical transaction data and SAU:4164's current price of ï·¼130.60, BlackRock Defensive Advantage Emerging Markets Fund's estimated gain on his SAU:4164 holdings is ï·¼-67,396.83, reflecting a -5.16% gain to date.
BlackRock Defensive Advantage Emerging Markets Fund SAU:4164 (ï·¼130.60) Holding Chart
BlackRock Defensive Advantage Emerging Markets Fund SAU:4164 (ï·¼130.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price ï·¼-/Share | ||
| Shares Sold | 0 | Average Price ï·¼-/Share | ||
| Current Price ï·¼0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
